These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23011962)

  • 21. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steering patients to relief from chronic low back pain: opioids' role.
    Chou R
    J Fam Pract; 2013 Mar; 62(3 Suppl):S8-13. PubMed ID: 23520591
    [No Abstract]   [Full Text] [Related]  

  • 23. Extended-release and long-acting opioids for chronic pain management.
    Sloan PA; Davis MP
    J Opioid Manag; 2015; Suppl():3-10. PubMed ID: 25539288
    [No Abstract]   [Full Text] [Related]  

  • 24. Opioids, pain management and the law.
    Stayner RS; Copenhaver DJ
    Curr Opin Anaesthesiol; 2012 Oct; 25(5):566-71. PubMed ID: 22914352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Certain opioids can preferably be administered transdermally].
    Jensen NM; Holmgaard R; Nielsen JB; Sørensen JA
    Ugeskr Laeger; 2015 Feb; 177(9):V09140487. PubMed ID: 25749289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 28. [Update on the use of opioids in acute, chronic, and breakthrough pain: an international symposium. Barcelona, February 2011].
    Pérez CJ
    Rev Esp Anestesiol Reanim; 2011; 58(7):462-4. PubMed ID: 22046872
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IBM rules on treating pain--physicians, be aware.
    Freeman J
    Iowa Med; 2012; 102(5):10. PubMed ID: 23472522
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of transdermal compounding in opioid safety.
    Bucher CV; Day AJ; Carvalho M
    J Opioid Manag; 2018; 14(1):17-22. PubMed ID: 29508892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacists' role in patient-provider pain management treatment agreements.
    Craig DS
    J Pharm Pract; 2012 Oct; 25(5):510-6. PubMed ID: 22842507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of transdermal opioids in patients in oncological remission suffering from chronic pain].
    Oberlé L; Luthy C; Pugliesi A; Pautex S; Piguet V
    Rev Med Suisse; 2015 Jun; 11(480):1385-9. PubMed ID: 26267944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General pharmacology of long-acting, extended-release, and sustained-release opioids for the treatment of chronic nonmalignant pain.
    Davis MP; Gamier P; Sloan PA
    J Opioid Manag; 2015; Suppl():11-20. PubMed ID: 25539289
    [No Abstract]   [Full Text] [Related]  

  • 35. [Situational administration of analgesics. Modern dosage forms for opioids].
    Bartholomäus J
    Pharm Unserer Zeit; 2002; 31(1):74-81. PubMed ID: 11852660
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.
    Labianca R; Sarzi-Puttini P; Zuccaro SM; Cherubino P; Vellucci R; Fornasari D
    Clin Drug Investig; 2012 Feb; 32 Suppl 1():53-63. PubMed ID: 22356224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-release opioids for the management of chronic non-malignant pain.
    Sloan P; Babul N
    Expert Opin Drug Deliv; 2006 Jul; 3(4):489-97. PubMed ID: 16822224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
    Sima L; Fang WX; Wu XM; Li F
    J Clin Pharm Ther; 2012 Feb; 37(1):27-31. PubMed ID: 21208247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.